Anbio Biotechnology
NNNN · XNASCIK 1982708fmd_1K7TM2D8C72XMRER78GR84PRACManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2022 to Dec 31, 2025, 4 periods
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading